Seeking men and women who have been hospitalized for moderate to severe COVID-19 for a study to evaluate whether adding one of several different immune modulators to standard care with remdesivir improves recovery from illness.
All participants in this study will be treated with remdesivir. Participants will also be randomly assigned to get one of several different investigational immune modulator drugs or placebo (looks like the investigational drug but contains no medicine).
What we're hoping for
We hope to evaluate whether adding an investigational immune modulator to treatment with remdesivir for moderate to severe COVID-19 in hospitalized adults improves the time to recovery.
ClinicalTrials.gov Identifier: NCT04593940